Services for pharmaceutical, medical device and ivd, food, feed and cosmetic companies
Medfiles supports its clients on the path of commercialisation with an array of services related to human and veterinary medicines, medical devices and in vitro diagnostic devices and food & feed and cosmetics. We assist our clients at all stages of the product lifecycle.
Our services cover strategic consultation and the entire product development process, starting with pharmaceutical development with quality control laboratory analyses (chemical and microbiological), implementing clinical trials (phases I to IV) and dealing with regulatory affairs (e.g. marketing authorisation, pharmacovigilance). Our one-stop service package offers a fluent and flexible solution for our clients’ outsourcing needs, for businesses of all sizes.
Learn more about Our Services
Client experience is at the heart of everything we do
Why Medfiles?
Over 35 years of experience in pharmaceutical and other healthcare industry. Proven track record and long-standing client relationships.
One-stop service provider – comprehensive services and tailored solutions for every client. We serve companies of all sizes, from start-ups to multinational corporations.
Not too big – not too small. Worktime and resources are organised to ensure maximum efficiency, without ever compromising our values – flexibility, reliability, fairness.
Contact us
Our clients:
NEws and events
Free webinar: Foods for Special Medical Purposes (FSMP) – an overview of EU legislation and regulatory classification
24.04.2024
What to know about medical device and IVD class changes and transition periods?
19.04.2024
Compliance review of promotional materials related to medicines, medical devices, food supplements and cosmetics in the Baltic countries
18.04.2024
Pharmaceutical-technological expertise ensuring successful drug development projects and manufacturing of IMPs
17.04.2024
Tenboron & Medfiles: working together in cancer drug development
15.04.2024
Free guide: Quick tips for successful CTIS submissions
04.04.2024